Molecular Oncology Meets Molecular Imaging: How Can We Prepare for the Future? Nov. 30, 10:30am-12:00pm

This session dives into the future of molecular oncology, introducing attendees to an array of topics, including: molecular targets and personalized treatments, with a focus on non-small cell lung cancer; novel PET tracers; the role of CT and MRI and radiogenomics.

When: Wed., Nov. 30, 10:30 to 12:00
Where: S406B

Speaker Information:

Ronald Korn, MD, PhD, CEO, Imaging Endpoints, Scottsdale, Ariz

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.